CRL - Company ID 0001100682
The table below shows CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $982.73M | $1.00B | $995.83M | $1.00B | $1.03B | $984.17M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported annual revenue of $4.02B for fiscal year 2025. That is down 0.9% from $4.05B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.68B (FY 2016) to $4.02B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $140.59M |
| $228.90M |
| $159.42M |
| $177.59M |
| $191.55M |
| $177.80M |
| Operating income | $202.64M | $119.89M | $119.90M | $133.80M | $100.13M | $74.67M |
| Income tax | -$163.79M | $53.93M | -$15.14M | $31.64M | $18.73M | $10.10M |
| Net income | $333.07M | -$1.48M | -$14.84M | $54.42M | $52.33M | $25.47M |
| EPS (diluted) | $6.86 | -$0.03 | -$0.30 | $1.10 | $1.06 | $0.50 |